Kane Biotech Inc. (KNBIF) has a market capitalization of $3.55M and trades at $0.02. The 52-week range is 0.02031-0.0704.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.9, Earnings Per Share (EPS) of $-0.02, annual revenue of $2.08M.
The stock has a beta of 0.24, operates in the Healthcare sector.